Organization
University Federico II
2 abstracts
Abstract
Impact of young age at diagnosis on survival outcomes in patients with early breast cancer according to tumor subtype: Pooled analysis of 5 randomized clinical trials from the Mammella InterGruppo (MIG) and Gruppo Italiano Mammella (GIM).Org: Department of Internal Medicine and Medical Sciences (DiMI), School of Medicine, University of Genova, Genova, Italy, Genoa, IT, Italy, Clinical Epidemiology Unit, IRCCS Ospedale Policlinico San Martino, Genoa, Italy, Istituto Nazionale Tumori Napoli IRCCS "Fondazione Pascale", Napoli, Italy, Department of Clinical Medicine and Surgery, University Federico II, Naples, Italy, Department of Medicine (DAME), University of Udine; Dipartimento di Oncologia Medica, Centro di Riferimento Oncologico di Aviano (CRO), IRCCS, Udine, Italy, Precision Medicine Unit in Senology Fondazione Policlinico Universitario Agostino Gemelli, IRCCS, Rome, Italy, IRCCS Sacro Cuore Don Calabria, Negrar Di Valpolicella, Italy, Clinical Oncology Department, IRCCS Ospedale Policlinico San Martino, Genoa, Italy, Department of Internal Medicine and Medical Specialties (DIMI), School of Medicine, University of Genoa, Genoa, Italy and Academic Trials Promoting Team, Institut Jules Bordet, Hôpital Universitaire de Bruxelles (HUB), Brussels, Belgium, IRCCS Azienda Ospedaliera Universitaria San Martino, Genova, Italy, Medical Research Council at UCL, London, United Kingdom, Department of Internal Medicine and Medical Specialties (DIMI), School of Medicine, University of Genova and Medical Oncology Department, U.O.C. Clinica di Oncologia Medica, IRCCS Ospedale Policlinico San Martino, Genova, Italy, Clinical Oncology Department, IRCCS Ospedale Policlinico San Martino Genoa, Genova, Italy, University of Genova, Genova, Italy, IRCCS Ospedale Policlinico San Martino, Istituto Nazionale Tumori Napoli IRCCS Fondazione Pascale, Napoli, Italy, University Federico II,
Abstract
Bendamustine-bortezomib-dexamethasone in relapsed/refractory multiple myeloma.Org: Hematology Unit, Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST) IRCCS, Meldola, Italy, Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST) IRCCS, University Federico II, Cimitile, Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori IRST (IRCCS) s,